Hydrogen sulfide treatment promotes glucose uptake by increasing insulin receptor sensitivity and ameliorates kidney lesions in type 2 diabetes

Antioxidants and Redox Signaling

Volumn 19, Issue 1, 2013, Pages 5-23

  Xue, Rong ^a   Hao, Dan Dan ^a   Sun, Ji Ping ^a   Li, Wen Wen ^a   Zhao, Man Man ^a   Li, Xing Hui ^a   Chen, Ying ^a   Zhu, Jian Hua ^b   Ding, Ying Jiong ^a   Liu, Jun ^a   Zhu, Yi Chun ^a  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTATHIONINE GAMMA LYASE; DEOXYGLUCOSE; HYDROGEN SULFIDE; INSULIN RECEPTOR; OXYGEN DERIVATIVE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SMALL INTERFERING RNA; SODIUM HYDROSULFIDE; UNCLASSIFIED DRUG; GLUCOSE; SODIUM BISULFIDE; SULFIDE;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GLOMERULUS; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; IN VITRO STUDY; IN VIVO STUDY; INSULIN RESISTANCE; INSULIN SENSITIVITY; KIDNEY INJURY; MALE; MYOTUBE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; 3T3 CELL LINE; ANIMAL; CELL CULTURE; DISEASE MODEL; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; INBRED RAT STRAIN; KIDNEY; METABOLISM; MOUSE; PATHOLOGY;

RATTUS; RATTUS NORVEGICUS;

3T3-L1 CELLS; ANIMALS; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; GLUCOSE; HYDROGEN SULFIDE; KIDNEY; MALE; MICE; RATS; RATS, INBRED STRAINS; RECEPTOR, INSULIN; SULFIDES;

EID: 84878827394     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2012.5024     Document Type: Article

References (32)

1. Baker MA, Cerniglia GJ, and Zaman A. Microtiter plate assay for the measurement of glutathione and glutathione disulfide in large numbers of biological samples. Anal Biochem 190: 360-365, 1990. (Pubitemid 20371981)
2. Brancaleone V, Roviezzo F, Vellecco V, De Gruttola L, Bucci M, and Cirino G. Biosynthesis of H2S is impaired in nonobese diabetic (NOD) mice. Br J Pharmacol 155: 673-680, 2008.
3. CaiWJ, WangMJ,Moore PK, JinHM, Yao T, and Zhu YC. The novel proangiogenic effect of hydrogen sulfide is dependent on Akt phosphorylation. Cardiovasc Res 76: 29-40, 2007. (Pubitemid 47362041)
4. Feng X, Chen Y, Zhao J, Tang C, Jiang Z, and Geng B. Hydrogen sulfide from adipose tissue is a novel insulin resistance regulator. Biochem Biophys Res Commun 380: 153-159, 2009.
5. Giacco F, Perruolo G, D'Agostino E, Fratellanza G, Perna E, Misso S, Saldalamacchia G, Oriente F, Fiory F, Miele C, Formisano S, Beguinot F, and Formisano P. Thrombinactivated platelets induce proliferation of human skin fibroblasts by stimulating autocrine production of insulinlike growth factor-1. FASEB J 20: 2402-2404, 2006.
6. Goldstein BJ, Bittner-Kowalczyk A, White MF, and Harbeck M. Tyrosine dephosphorylation and deactivation of insulin receptor substrate-1 by protein-tyrosine phosphatase 1B. Possible facilitation by the formation of a ternary complex with the GRB2 adaptor protein. J Biol Chem 275: 4283-4289, 2000. (Pubitemid 30094668)
7. Huang C, Somwar R, Patel N, Niu W, Torok D, and Klip A. Sustained exposure of L6 myotubes to high glucose and insulin decreases insulin-stimulated GLUT4 translocation but upregulates GLUT4 activity. Diabetes 51: 2090-2098, 2002. (Pubitemid 34729012)
8. Ji Y, Pang QF, Xu G, Wang L, Wang JK, and Zeng YM. Exogenous hydrogen sulfide postconditioning protects isolated rat hearts against ischemia-reperfusion injury. Eur J Pharmacol 587: 1-7, 2008.
9. Joseph JW, Koshkin V, Zhang CY, Wang J, Lowell BB, Chan CB, and Wheeler MB. Uncoupling protein 2 knockout mice have enhanced insulin secretory capacity after a high-fat diet. Diabetes 51: 3211-3219, 2002. (Pubitemid 35246967)
10. Kamoun P. Endogenous production of hydrogen sulfide in mammals. Amino Acids 26: 243-254, 2004. (Pubitemid 38829787)
11. Khan AH and Pessin JE. Insulin regulation of glucose uptake: a complex interplay of intracellular signalling pathways. Diabetologia 45: 1475-1483, 2002.
12. Kim JB and Spiegelman BM. ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Genes Dev 10: 1096-1107, 1996. (Pubitemid 26152851)
13. Kumar N and Dey CS. Metformin enhances insulin signalling in insulin-dependent and-independent pathways in insulin resistant muscle cells. Br J Pharmacol 137: 329-336, 2002.
14. Lautt WW. The HISS story overview: a novel hepatic neurohumoral regulation of peripheral insulin sensitivity in health and diabetes. Can J Physiol Pharmacol. 77: 553-562, 1999.
15. Lefer DJ. Potential importance of alterations in hydrogen sulphide (H2S) bioavailability in diabetes. Br J Pharmacol 155: 617-619, 2008.
16. Lowicka E, Be1towski J. Hydrogen sulfide (H2S)-the third gas of interest for pharmacologists. Pharmacol Rep 59: 4-24, 2007. (Pubitemid 46522698)
17. Olefsky JM. Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists. J Clin Invest 106: 467-472, 2000. (Pubitemid 30666379)
18. Pan TT, Chen YQ, and Bian JS. All in the timing: a comparison between the cardioprotection induced by H2S preconditioning and post-infarction treatment. Eur J Pharmacol 616: 160-165, 2009.
19. Pliquett RU, Fasshauer M, Blü her M, Paschke R. Neurohumoral stimulation in type-2-diabetes as an emerging disease concept. Cardiovasc Diabetol 3: 1-8, 2004.
20. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, and Bennett PH. Sequential changes in serum insulin concentration during development of non-insulin-dependent diabetes. Lancet 1: 1356-1359, 1989. (Pubitemid 19151955)
21. Saltiel AR and Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414: 799-806, 2001. (Pubitemid 34000783)
22. Saltiel AR and Pessin JE. Insulin signaling pathways in time and space. Trends Cell Biol 12: 65-71, 2002. (Pubitemid 34146521)
23. Shi YX, Chen Y, Zhu YZ, Huang GY, Moore PK, Huang SH, Yao T, and Zhu YC. Chronic sodium hydrosulfide treatment decreases medial thickening of intramyocardial coronary arterioles, interstitial fibrosis, and ROS production in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 293: 2093-2100, 2007.
24. Smit L and Borst J. The Cbl family of signal transduction molecules. Crit Rev Oncog 8: 359-379, 1997. (Pubitemid 28243524)
25. Sun YG, Cao YX, Wang WW, Ma SF, Yao T, and Zhu YC. Hydrogen sulphide is an inhibitor of L-type calcium channels and mechanical contraction in rat cardiomyocytes. Cardiovasc Res 79: 632-641, 2008.
26. Thomson MJ, Williams MG, and Frost SC. Development of insulin resistance in 3T3-L1 adipocytes. J Biol Chem 272: 7759-7764, 1997. (Pubitemid 27137330)
27. Wang R. Hydrogen sulfide: the third gasotransmitter in biology and medicine. Antioxid Redox Signal 12: 1061-1064, 2010.
28. Wang MJ, Cai WJ, Li N, Ding YJ, Chen Y, and Zhu YC. The hydrogen sulfide donor NaHS promotes angiogenesis in a rat model of hind limb ischemia. Antioxid Redox Signal 12: 1065-1077, 2010.
29. Wu L, Yang W, Jia X, Yang G, Duridanova D, Cao K, and Wang R. Pancreatic islet overproduction of H2S and suppressed insulin release in Zucker diabetic rats. Lab Invest 89: 59-67, 2009.
30. Yao LL, Huang XW, Wang YG, Cao YX, Zhang CC, and Zhu YC. Hydrogen sulfide protects cardiomyocytes from hypoxia/reoxygenation-induced apoptosis by preventing GSK-3beta-dependent opening of mPTP. Am J Physiol Heart Circ Physiol 298:H1310-1319, 2010.
31. Yusuf M, Kwong Huat BT, Hsu A, Whiteman M, Bhatia M, and Moore PK. Streptozotocin-induced diabetes in the rat is associated with enhanced tissue hydrogen sulfide biosynthesis. Biochem Biophys Res Commun 333: 1146-1152, 2005. (Pubitemid 40910123)
32. Zhong G, Chen F, Cheng Y, Tang C, and Du J. The role of hydrogen sulfide generation in the pathogenesis of hypertension in rats induced by inhibition of nitric oxide synthase. J Hypertens 21: 1879-1885, 2003. (Pubitemid 37290106)